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Sir–With great interest we read the paper of Ullmark et al. 
on using positron emission tomography (PET) to assess bone 
metabolic  activity  (Ullmark  et  al.  2009).  PET  is  an  imag-
ing tool that can provide functional rather than morphologi-
cal information, and has thus attracted a lot of attention. The 
prerequisites  for  proper  analysis  and  subsequent  sufficient 
interpretation are very important, and most of these originate 
from the principles of PET. Unfortunately, Ullmark et al. do 
not address these important issues and, to avoid misinterpreta-
tions, we wish to highlight some of these important points.
The principle of positron emission tomography PET scan-
ning is based on a short-lived radioactive tracer, which decays 
by emitting a positron. The tracers can exist as single isotopes 
or be incorporated in larger molecules, depending on the appli-
cation. This method suffers from low spatial resolution. Apart 
from single-positron emission tomography (SPECT), all PET 
systems utilize coincidence detection of the annihilation pho-
tons from positron decay. Since the paired gamma rays from 
the annihilation of the positron are anti-parallel, the detection 
of the gamma rays determines a line of response (LOR) along 
which the annihilation took place. Resolution is thus deter-
mined by the size/density of the detectors that are most often 
placed in a ring around the subject. However, the LOR is not 
completely linear and the gamma rays are released in a direc-
tion of 180° ± 0.5°. This physical phenomenon further limits 
the resolution. The spatial resolution of most clinical PET 
scanners is therefore only about 6–8 mm (Townsend 2004). 
Hence, the resulting images are known to be affected by par-
tial-volume effects, which can cause small regions with high 
tracer uptake to be imaged as having an artificially low con-
centration and vice versa (Soret et al. 2007). When compar-
ing regions of interest (ROIs), it is therefore important for the 
accuracy that the size is sufficiently high or that the tissue sur-
rounding the ROIs has a comparable uptake of the tracer. For 
the reader to be able to interpret PET data, describing the size 
of the ROI is as important as the obvious adding of standard 
deviations to the results. The three basic analytical methods 
with or without blood sampling will not be addressed here.
In orthopedic approaches, the use of the fluoride isotope 
[18F] is of particular interest because of its incorporation into 
the bone crystals. However, due to the rate of bone forma-
tion, [18F] is not incorporated into bone during a 1- to 2-hour 
scan. The fluoride ion exchanges with the hydroxyl groups in 
the hydroxyapatite crystal of bone (Ca10(PO4)6OH2) to form 
fluoroapatite (Ca10(PO4)6F2), and this can be interpreted as a 
4-step event, which was originally described by Blau et al. as 
early as 1962—long before PET gained its clinical popular-
ity and accessibility. The first 2 steps from the blood through 
extracellular space to the shell of bound water around exposed 
crystals are very rapid (minutes), step 2 being the irreversible 
step. Step 3 is the traveling of the tracer onto the crystal sur-
face, and this is probably measured in hours. The final step of 
incorporation, step 4, may take days or weeks. Consequently, 
areas of high uptake result from processes that increase the 
exposed bone crystal surface and/or increase blood flow. Thus, 
areas  of  osteoclastic  and  osteoblatic  activity  are  measured 
equally, and this is of crucial importance when interpreting 
these data sets (Blau et al. 1972).
By directly translating SUV to “bone forming activity”, Ull-
mark et al. draw a dicey conclusion. This translation is appar-
ently based on a study by Piert et al. correlating metabolic 
activity in the vertebral body from PET and histomorphometry 
in an iliac crest biopsy (Piert et al. 2001). However, that study 
investigated bone blood flow and metabolic rate in untreated 
bone, which most likely presents a steady state metabolic rate. 
This is obviously very different from new bone formation in 
an allograft-implanted area. The findings at 1 week postopera-
tively in Ullmark’s study could very well be due to impaired 
blood flow in the impacted graft rather than being an assess-
ment of metabolic rate per se (Berding et al. 1995, Piert et al. 
1998). Furthermore, there is evidence that radiotracer uptake 
is not dependent on osteoblast number, but concentration of 
bone-forming minerals (Toegel et al. 2006). It is therefore 
important to notice that areas of osteoclastic and osteoblas-
tic activity are labeled equally, and thus increased resorption 
would also result in increased tracer uptake without it neces-
sarily resulting in a net increase in bone volume (Blau et al. 
1972, Genant et al. 1974).
Combined PET/CT and (most recently) PET/MRI scanners 
make it possible to correlate the functional data from PET 
with morphological images (Foldager et al. 2008). This has 
two advantages. First, it gives an exact morphological location 
of the metabolic event and secondly, ROIs can be made from 
CT or MRI images alone, which makes the placement of these 
more accurate and furthermore limits possible inter-observer 
errors.
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PET is indeed a fast-growing modality and both PET and 
cyclotron centers are opening and expanding in the western 
countries, thereby increasing accessibility for researchers in 
the field of orthopedics. We therefore find it very important 
that the limitations as well as the opportunities of this power-
ful tool are properly addressed and well understood to avoid 
misinterpretations and misunderstanding of this rather com-
plex imaging modality.
Casper Bindzus Foldager, Michael Bendtsen, Cody Bünger
Orthopaedic Research Laboratory, 
Aarhus University Hospital, Denmark
foldager@ki.au.dk
Sir—We welcome this discussion initiated by Foldager et al. 
for several reasons. Fluoride PET has been available for 10–15 
years in academic PET centers such as Uppsala and Aarhus, 
but reports on the use of this tool for orthopedic research are 
still scarce. A large increase in availability of fluoride PET is 
anticipated in the coming years, as more clinically-oriented 
PET centers introduce fluoride PET/CT for routine scanning 
in benign and malignant bone diseases (Grant et al. 2008). 
This development is good news for researchers in orthopedics, 
and will probably spark a range of novel approaches for non-
invasive studies of bone metabolism. Nonetheless, each new 
technology comes with its pros and cons. 
The true power of PET lies in its capacity for absolute quan-
tification, i.e. the concentration of tracer substance is mea-
sured with high accuracy. When novel tracers and applica-
tions are probed for biological relevance, such measurements 
typically require advanced set-ups and lengthy investigations. 
Foldager et al. reference their own paper (2008) in which the 
18F-fluoride flux from plasma to bone was calculated using 
simultaneous  radioactivity  sampling  of  tissue,  by  dynamic 
imaging, and blood, by arterial lines. However, to facilitate a 
human study in a clinical setting with repeated measurements, 
it appears highly relevant to search for a simplified approach. 
In a previous paper (Sörensen et al. 2003) we validated the use 
of SUV measurements in human femoral allografts 40 min 
after tracer injection against the more rigorous method also 
employed by Foldager et al. The correlation over a wide range 
of metabolic activity was r = 0.97, indicating that SUVs and 
Gjedde-Patlak plots perform equally in this setting. Further-
more, the long-term reproducibility of both measurements is 
12–14% in normal bone (Frost et al. 2008). The use of SUVs 
for quantification also allows the entire skeleton to be exam-
ined in one session. That first paper also discussed the PET 
technology in general terms. We are confident about the use 
of simplified quantification in the hip area, but would encour-
age future researchers engaging other parts of the skeleton to 
perform validating work.
Another important technical aspect to take into consider-
ation when planning a study is the details related to the graphi-
cal analysis of images. Foldager et al. specifically point out the 
partial volume problem (i.e. the measurement of local activity 
is affected by the activity in surrounding tissues due to blur-
ring in images). This is a fact that has to be dealt with in all 
imaging studies to some degree, and the rationale for our use 
of ROIs of at least 1 cm2. 
Bone mineralization
Foldager et al. raise an issue on the interpretation of fluoride 
uptake and refer to the original work performed by Blau et 
al. (1972). The question is whether or not the PET signal is 
exclusively related to new bone formation. It was previously 
assumed that 18F-fluoride would accumulate in mineral cre-
ated both by osteoblasts and clasts. More recent information 
appears to support a view that 18F-fluoride is bound only to 
the mineral formed and fixated by the osteoblasts (Anderson 
2003, Toegel et al. 2006). Osteoclasts degrade bone material 
internally and expel the debris by a mechanism of transcyto-
sis to the extracellular space (Salo et al. 1997). Although not 
rigorously proven, naked mineral in resorption zones to which 
free fluoride ions from the extracellular space could attach is 
not likely to exist in vivo. For example, osteolytic metastases 
only have a faint rim uptake on PET and radiated bone has 
virtually no uptake at all despite continuous demineralization 
and relatively normal perfusion. This means that an integrated 
assessment  of  bone  remodeling  cannot  be  performed  with 
fluoride PET alone. 
The problem of PET and CT
As Foldager et al. state, the fusion of images from both PET 
and either MRI or CT greatly improves our understanding of 
the biology. So far, PET/MRI exists only as prototypes. Inte-
grated PET/CT devices have been commercially available for 
a few years. The first clinical PET/CT scanner in Sweden was 
installed in early 2005 in Uppsala. Some of the projects in our 
group started earlier than that. For the experienced interpreter, 
uptake in fluoride PET images is relatively easy to locate ana-
tomically even without CT. The use of the integrated device 
poses a problem in orthopedics, because of the artifacts pro-
duced by CT at the level of metallic implants. Since the CT 
component of PET/CT is used to correct for photon attenua-
tion, the final PET images also contain artifacts (Goerres et al. 
2003). This device is therefore not very useful in several of our 
projects. Older-generation PET scanners correctly assess the 
uptake concentration surrounding implants and are therefore 
preferable for quantification. Fortunately, the PET Center in 
Uppsala has 2 of these machines. In some ongoing projects, 
we use separately obtained CT or MRI for more exact anatom-
ical location. Still, patient motion during a scan or incorrect 
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To summarize, we agree with Foldager et al. that there are 
several technical aspects of PET that need to be attended to 
before meaningful results can be obtained. Most likely, very 
few orthopedics researchers will opt for mastering this highly 
technical discipline and successful projects therefore require 
early liaisons between specialists.
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